ArticleAdvances in radiation oncology2024

Tolerance of Concurrent Adjuvant Radiation Therapy and Pembrolizumab for Triple Negative Breast Cancer: Real Life Experience.

Thais Tison et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.